ERIS Lifesciences consolidated net profit declines 8.19% in the September 2018 quarter
Sales rise 12.96% to Rs 260.56 crore
Net profit of ERIS Lifesciences declined 8.19% to Rs 85.51 crore in the quarter ended September 2018 as against Rs 93.14 crore during the previous quarter ended September 2017. Sales rose 12.96% to Rs 260.56 crore in the quarter ended September 2018 as against Rs 230.66 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales260.56230.66 13 OPM %38.6442.38 -PBDT100.59104.19 -3 PBT92.3198.92 -7 NP85.5193.14 -8Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 03 2018 | 5:24 PM IST